BE385316A - - Google Patents
Info
- Publication number
- BE385316A BE385316A BE385316DA BE385316A BE 385316 A BE385316 A BE 385316A BE 385316D A BE385316D A BE 385316DA BE 385316 A BE385316 A BE 385316A
- Authority
- BE
- Belgium
- Prior art keywords
- solution
- parts
- water
- solutions
- hydrochloride
- Prior art date
Links
- 239000000243 solution Substances 0.000 claims description 27
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims description 9
- XUWHAWMETYGRKB-UHFFFAOYSA-N 2-Piperidinone Chemical class O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 230000000240 adjuvant Effects 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 claims description 3
- 229960000846 Camphor Drugs 0.000 claims description 3
- 241000723346 Cinnamomum camphora Species 0.000 claims description 3
- -1 alkaloid salts Chemical class 0.000 claims description 3
- 229930013930 alkaloids Natural products 0.000 claims description 3
- 229930007890 camphor Natural products 0.000 claims description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 230000003381 solubilizing Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000001096 (4-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol hydrochloride Substances 0.000 description 7
- LBSFSRMTJJPTCW-DSXUQNDKSA-N (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)C=C)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LBSFSRMTJJPTCW-DSXUQNDKSA-N 0.000 description 7
- 229960001811 Quinine Hydrochloride Drugs 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 5
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N Theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- GGYVTHJIUNGKFZ-UHFFFAOYSA-N 1-methylpiperidin-2-one Chemical compound CN1CCCCC1=O GGYVTHJIUNGKFZ-UHFFFAOYSA-N 0.000 description 3
- IMUHWLVEEVGMBC-BKUXTCEESA-N (S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-quinolin-4-ylmethanol;hydron;chloride Chemical compound Cl.C1=CC=C2C([C@@H]([C@@H]3N4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 IMUHWLVEEVGMBC-BKUXTCEESA-N 0.000 description 2
- VUQMOERHEHTWPE-UHFFFAOYSA-N 1-ethylpiperidin-2-one Chemical compound CCN1CCCCC1=O VUQMOERHEHTWPE-UHFFFAOYSA-N 0.000 description 2
- QVEMWYGBLHQEAK-UHFFFAOYSA-N 2-ethylbutanamide Chemical compound CCC(CC)C(N)=O QVEMWYGBLHQEAK-UHFFFAOYSA-N 0.000 description 2
- AUVVAXYIELKVAI-CKBKHPSWSA-N Emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 2
- 229960001923 Emetine Hydrochloride Drugs 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 229960000278 Theophylline Drugs 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000001264 neutralization Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- MIMJFNVDBPUTPB-UHFFFAOYSA-N potassium hexacyanoferrate(3-) Chemical compound [K+].[K+].[K+].N#C[Fe-3](C#N)(C#N)(C#N)(C#N)C#N MIMJFNVDBPUTPB-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- LJOQGZACKSYWCH-WZBLMQSHSA-N (R)-[(2S,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol Chemical compound C1=C(OC)C=C2C([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 LJOQGZACKSYWCH-WZBLMQSHSA-N 0.000 description 1
- DVVGIUUJYPYENY-UHFFFAOYSA-N 1-methylpyridin-2-one Chemical compound CN1C=CC=CC1=O DVVGIUUJYPYENY-UHFFFAOYSA-N 0.000 description 1
- GCNTZFIIOFTKIY-UHFFFAOYSA-N 1H-pyridin-4-one Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 1
- ZFCLAKPTEFRHMA-UHFFFAOYSA-N 2,2,6-trimethylpiperidin-4-one Chemical compound CC1CC(=O)CC(C)(C)N1 ZFCLAKPTEFRHMA-UHFFFAOYSA-N 0.000 description 1
- 229940091110 Antipyrine Drugs 0.000 description 1
- UORJNBVJVRLXMQ-UHFFFAOYSA-N Aprobarbital Chemical compound C=CCC1(C(C)C)C(=O)NC(=O)NC1=O UORJNBVJVRLXMQ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N Carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241000434299 Cinchona officinalis Species 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N Phenazone Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 229960000948 Quinine Drugs 0.000 description 1
- CESKLHVYGRFMFP-UHFFFAOYSA-N Sulfonmethane Chemical compound CCS(=O)(=O)C(C)(C)S(=O)(=O)CC CESKLHVYGRFMFP-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- GPAYXCOQADGNAZ-UHFFFAOYSA-N [2-(methylamino)acetyl] 2-(methylamino)acetate Chemical compound CNCC(=O)OC(=O)CNC GPAYXCOQADGNAZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 229940051880 analgesics and antipyretics Pyrazolones Drugs 0.000 description 1
- 230000001754 anti-pyretic Effects 0.000 description 1
- 229960003153 aprobarbital Drugs 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229960004251 hydroquinine Drugs 0.000 description 1
- 230000001622 hypnogenic Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000003522 irritant Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000926 not very toxic Toxicity 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- JWBPVFVNISJVEM-UHFFFAOYSA-M sodium;1,3,7-trimethylpurine-2,6-dione;benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1.CN1C(=O)N(C)C(=O)C2=C1N=CN2C JWBPVFVNISJVEM-UHFFFAOYSA-M 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE385316A true BE385316A (de) |
Family
ID=54194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE385316D BE385316A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE385316A (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2722984A1 (fr) * | 1994-07-26 | 1996-02-02 | Effik Laboratoires | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
-
0
- BE BE385316D patent/BE385316A/fr unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2722984A1 (fr) * | 1994-07-26 | 1996-02-02 | Effik Laboratoires | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
| WO1997004749A1 (fr) * | 1994-07-26 | 1997-02-13 | Laboratoires Effik | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
| EP0761208A1 (de) * | 1994-07-26 | 1997-03-12 | Laboratoires EFFIK | Verfahren zur Herstellung trockener Arzneiformen sowie die auf diese Weise erhaltenen Zusammensetzungen |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0669131B1 (de) | Wässrige konzentrierte Lösungen enthaltend Argatroban | |
| CA2102777C (fr) | Nouvelles compositions a base de derives de la classe des taxanes | |
| EP0078785B1 (de) | Salze der Valproinsäure, ihre Herstellung und ihre Verwendung | |
| CH630260A5 (fr) | Compositions antibiotiques a base d'une tetracycline. | |
| CA2169747A1 (fr) | Sel de nimesulide hydrosoluble et leurs utilisations pour le traitement des affections inflammatoires | |
| JPH03849B2 (de) | ||
| JPH057371B2 (de) | ||
| JP2008502723A (ja) | 治療活性剤、クエン酸または共役塩基、および二酸化塩素を含む安定化された組成物 | |
| LU83423A1 (fr) | Pneumatique radial pour vehicules tout-terrain | |
| JPH02255652A (ja) | ベンゼンスルホンアミド類およびその製造方法 | |
| EP0605646B1 (de) | Sparfloxacin-Salze und sie enthaltende Lösungen | |
| BE385316A (de) | ||
| EP0099799B1 (de) | Salze von alpha-Amino(und Imino)-Säure, omega-Sulfon N-substituiert, kationische Vektoren mit hoher cellularer Penetration und Herstellungsverfahren | |
| CH644015A5 (fr) | Solution aqueuse injectable a base d'oxytetracycline. | |
| LU83363A1 (fr) | Compositions antitumeurs | |
| WO2004030665A1 (en) | Transparent gel composition, for the administration of diclofenac sodium through the skin | |
| HU177873B (en) | Further developped process for preparing an aequous solution containing a complex of n-/3-chloro-4-/4-chloro-phenoxy/-phenyl/-2-hydroxy-3,5-diiodo-benzamide with polyvinyl-pyrrolidone | |
| EP0599943A1 (de) | Leukotriene-receptor-antagonist-antihistamine komplex | |
| CH642378A5 (fr) | Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique. | |
| TWI316403B (en) | Glycyrrhizin containing pharmaceutical composition | |
| FR2624736A1 (fr) | Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole | |
| US1913323A (en) | Stable concentrated solution for therapeutic purposes | |
| EP0092287A2 (de) | Acetylcystein-Salze, ihre Herstellung und Verwendung | |
| JP4338517B2 (ja) | グアニジン誘導体の塩及び該塩から成る製薬学的調剤 | |
| FR2535205A1 (fr) | Solution pour injection a base de substances antirhumatismales et d'une cobalamine et procede pour sa preparation |